Sirona Biochem Corp. (CVE:SBM – Get Free Report) shares traded down 16.7% during trading on Tuesday . The stock traded as low as C$0.05 and last traded at C$0.05. 113,000 shares changed hands during trading, an increase of 91% from the average session volume of 59,069 shares. The stock had previously closed at C$0.06.
Sirona Biochem Price Performance
The company has a current ratio of 0.34, a quick ratio of 2.41 and a debt-to-equity ratio of 219.21. The stock has a market cap of C$12.84 million, a P/E ratio of -5.00 and a beta of -0.03. The business has a 50-day simple moving average of C$0.06 and a 200 day simple moving average of C$0.06.
About Sirona Biochem
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.
Recommended Stories
- Five stocks we like better than Sirona Biochem
- What Are Dividend Achievers? An Introduction
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- High Flyers: 3 Natural Gas Stocks for March 2022
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- What Are Some of the Best Large-Cap Stocks to Buy?
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Sirona Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sirona Biochem and related companies with MarketBeat.com's FREE daily email newsletter.
